.
Search
Dr. Will Gibson and Dr. C. Michael Gibson discuss how p53 was once considered an undruggable target for cancer therapy.
A new article in the NEJM raises hope that there may be a path forward. Dr. Will Gibson, an oncologist at […]
Dr. Nihar Desai and I discuss how practice is moving toward
We talk about the importance of MDs reviewing AI output and the timing of CT reassessment of risk Sponsored by […]